Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.

Kim, Junwon; Lee, Doohyun; Park, Changmin; So, Wonyoung; Jo, Mina; Ok, Taedong; Kwon, Jeongjin; Kong, Sunju; Jo, Suyeon; Kim, Youngmi; Choi, Jihyun; Kim, Hyoung Cheul; Ko, Yoonae; Choi, Inhee; Park, Youngsam; Yoon, Jaewan; Ju, Moon Kyeong; Kim, Junghwan; Han, Sung-Jun; Kim, Tae-Hee; Cechetto, Jonathan; Nam, Jiyoun; Sommer, Peter; Liuzzi, Michel; Lee, Jinhwa; No, Zaesung

Kim, Junwon; Lee, Doohyun; Park, Changmin; So, Wonyoung; Jo, Mina; Ok, Taedong; Kwon, Jeongjin; Kong, Sunju; Jo, Suyeon; Kim, Youngmi; Choi, Jihyun; Kim, Hyoung Cheul; Ko, Yoonae; Choi, Inhee; Park, Youngsam; Yoon, Jaewan; Ju, Moon Kyeong; Kim, Junghwan; Han, Sung-Jun; Kim, Tae-Hee; Cechetto, Jonathan; Nam, Jiyoun; Sommer, Peter; Liuzzi, Michel; Lee, Jinhwa; No, Zaesung.

Afiliação

Kim J; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Lee D; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Park C; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
So W; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Jo M; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Ok T; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Kwon J; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Kong S; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Jo S; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Kim Y; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Choi J; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Kim HC; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Ko Y; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Choi I; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Park Y; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Yoon J; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Ju MK; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Kim J; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Han SJ; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Kim TH; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Cechetto J; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Nam J; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Sommer P; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Liuzzi M; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
Lee J; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam
No Z; Medicinal Chemistry 2, Medicinal Chemistry 1, Medicinal Chemistry 3, Drug Biology Group, Screening Technology Platforms Group, DMPK Group, Cell Biology of Retroviruses Group, Early Discovery Program, and Late Discovery Program, Institut Pasteur Korea (IP-K) , Sampyeong-dong 696, Bundang-gu, Seongnam